2006
DOI: 10.1093/medlaw/fwl001
|View full text |Cite
|
Sign up to set email alerts
|

Is the Gift Still Good? Examining the Politics and Regulation of Blood Safety in the European Union

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(24 citation statements)
references
References 0 publications
0
24
0
Order By: Relevance
“…The political sensitivity of relying on paid plasma donors to supply health-care requirements in the EU is such that it is difficult to confirm up to date figures for the plasma economy. However, data from the 1990s point to over 50 per cent of the EU market being sourced from plasma collected in the United States (Farrell, 2006). …”
Section: Governing the Blood Supply In Europementioning
confidence: 99%
“…The political sensitivity of relying on paid plasma donors to supply health-care requirements in the EU is such that it is difficult to confirm up to date figures for the plasma economy. However, data from the 1990s point to over 50 per cent of the EU market being sourced from plasma collected in the United States (Farrell, 2006). …”
Section: Governing the Blood Supply In Europementioning
confidence: 99%
“…On the other hand, current EU regulations on blood safety accept as given the fact that most European countries favour a system of unpaid donors. The lessons from the AIDS disaster have, as Farrell (2006) argues, not been sufficiently drawn. The dilemma, evident in the Swedish health authorities’ initial reactions, still holds between a risk of insufficient supply of blood as opposed to a risk of infection.…”
Section: Discussionmentioning
confidence: 99%
“…36 In any case, it is suggested that there is a need to be responsive to consumer demand and choice in allowing such products to circulate in the EU blood market, given national shortages in the area. Although this debate has been described as an inadequate frame of reference for taking account of the now complex inter-relationship between ethical, socio-cultural and economic issues affecting blood quality and safety, 37 the fraught negotiations over the Blood Directive made it clear that this debate nevertheless has the potential to generate significant political conflict in circumstances where public support remains strong for the retention of the gift relationship in blood donation. 38 In the circumstances, EU decision-makers were forced to find a way forward which would accommodate the opposing sides in this debate, as well as achieve an acceptable political compromise that would allow for the adoption of the Directive.…”
Section: Eu Governance Of Human Materialsmentioning
confidence: 99%
“…This was designed to ensure that standard-setting in relation to technical requirements set out in the Blood Directive also applied to the collection and testing of the human blood and human plasma used in such products. 48 Risk governance in relation to such products at an institutional level takes place under the auspices of the European Medicines Agency. Risk assessment and evaluation of such products is largely overseen by scientific experts in this technocratic environment, far removed from the political sphere in which the Blood Directive was adopted and its implementation continues to be monitored.…”
Section: Eu Governance Of Human Materialsmentioning
confidence: 99%